Beaten-Down Biotech Just Lost a Backer — Should You Care
When a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
Plan zero based budgets for families to create a shared financial vision, allocate funds, and pursue common goals together.
19,937 articlesWhen a biotech firm loses a meaningful backer, investors face a pivotal moment. This guide explains what it signals, ...
The National Association of Realtors unveiled three guidance resources to clarify MLS data rules for brokers and MLSs...
Massive performance-based bonuses paid to semiconductor workers are drawing scrutiny from the Bank of Korea as the ce...
In 2026, investors face a choice between a specialized look at nuclear power and the broader oil and gas market. This...
World Cup fever meets a new kind of betting on Kalshi’s prediction-market platform. The company says it’s not a sport...
Rivian faces a challenging journey into 2026, with big questions about profitability, demand, and policy shifts. This...
CrowdStrike has pulled back from recent highs. Before March 3 earnings, investors wonder if a dip offers a real buyin...
As Alphabet treads into 2026, three driving forces could shape its trajectory: AI-powered growth, smarter ads monetiz...
A veteran MIT roboticist who cofounded bankrupt robot iRobot cautions that Elon Musk's humanoid vision is not close t...
A surprise accounting disclosure sent Driven Brands shares skidding. This guide breaks down what happened, how to ass...
When Berkshire Hathaway's Greg Abel takes the stage as Buffett’s successor, the market watches not for flashy moves b...
Warren Buffett’s transition at Berkshire Hathaway ushers in a new era. Yet three longtime favorites—Apple, American E...